ERDAFITINIB 4 mg (Erdanat) x 28 Tablets

~~$800.00~~ $390.00

Prescription Required

Erdafitinib 4 mg (Erdanat) is a targeted anticancer medicine used to treat certain FGFR (fibroblast growth factor receptor)-altered cancers, especially locally advanced or metastatic urothelial (bladder) cancer. This medicine is prescribed only for patients with confirmed FGFR genetic alterations and should be used under the supervision of an oncologist.

Generic name	Erdafitinib
Strength	4 mg
Manufacturer	Natco
Package size	28 Tablets
Used for	Advanced or metastatic bladder cancer (urothelial carcinoma)
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries.

Enquire via WhatsApp

Uses of ERDAFITINIB 4 mg (Erdanat)

Treats FGFR-altered urothelial (bladder) cancer
Used for locally advanced or metastatic disease
Helps slow cancer progression
Used after certain previous treatments
Part of targeted cancer therapy

Benefits

Targets cancer cells with FGFR alterations
Slows tumour growth
Delays disease progression
May improve treatment outcomes
Convenient oral therapy

How Does ERDAFITINIB 4 mg Work?

Erdafitinib is an FGFR (fibroblast growth factor receptor) inhibitor that blocks abnormal FGFR proteins responsible for sending growth signals to cancer cells. By stopping these signals, it slows the growth, multiplication, and spread of cancer cells.

Side Effects

Mouth sores
Dry mouth
Diarrhoea
Fatigue
Nail changes
Dry skin
Increased phosphate levels
Eye or vision problems

Precautions

Take the medicine exactly as prescribed.
Have regular eye examinations during treatment.
Monitor phosphate levels through regular blood tests.
Inform your doctor immediately if you notice blurred vision or other eye problems.
Tell your healthcare provider about all medicines and supplements you are taking.
Avoid pregnancy during treatment and follow your doctor’s advice on contraception.
Attend regular follow-up appointments to monitor treatment response and side effects.

Author

Reviewed By

Dr. Neeru Mehta

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.